Back

VJHemOnc is committed to improving our service to you

iwNHL 2018 | Novel diagnostics & biomarkers for DLBCL and CTCL

VJHemOnc is committed to improving our service to you

Bjoern Chapuy, Nicolas Ortonne and Thomas Habermann

In this session, Thomas Habermann, MD, of the Mayo Clinic, Rochester, MI, chairs a discussion with Bjoern Chapuy, PhD, MD, from the Dana-Farber Cancer Institute, Boston, MA, and Nicolas Ortonne, MD, PhD, of Henri Mondor University Hospital, Créteil, France. The group explore actionable genetic signatures for diffuse large B-cell lymphoma, and biomarkers for the diagnosis and treatment of cutaneous T-cell lymphoma. This discussion was recorded at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter